Safety of immune checkpoint inhibitor rechallenge after severe immune-related adverse events: a retrospective analysis.

Autor: Eldani C; Department of Dermatology, Centre Hospitalier Universitaire (CHU) Bordeaux, Bordeaux, France., Kostine M; Department of Rheumatology, CHU Bordeaux, Bordeaux, France., Faure M; Department of Cardiology, CHU Bordeaux, Bordeaux, France., Lazaro E; Department of Internal Medicine, Haut-Leveque, Bordeaux University Hospital, Bordeaux, France., Rigothier C; Department of Nephrology, Transplantation, and Dialysis, Bordeaux University Hospital Center, Bordeaux, France., Hiriart JB; Hepatology Unit, Bordeaux University Hospital, Bordeaux, France., Teulières B; Department of Gastroenterology and Hepatology, Centre Médico-chirurgical Magellan, Hôpital Haut-Lévêque, CHU de Bordeaux, Bordeaux, France., Poullenot F; Department of Gastroenterology and Hepatology, Centre Médico-chirurgical Magellan, Hôpital Haut-Lévêque, CHU de Bordeaux, Bordeaux, France., Haissaguerre M; Department of Endocrinology, University Hospital of Bordeaux, Bordeaux, France., Zysman M; Pulmonary Department, Pôle Cardio-thoracique, CHU de Bordeaux, Bordeaux, France., Veillon R; Pulmonary Department, Pôle Cardio-thoracique, CHU de Bordeaux, Bordeaux, France., Vergnenegre C; Pulmonary Department, Pôle Cardio-thoracique, CHU de Bordeaux, Bordeaux, France., Issa N; Intensive Care Unit and Infectious Disease, University Hospital Centre Bordeaux, Bordeaux, France., Domblides C; Department of Medical Oncology, Bordeaux University Hospital, Bordeaux, France., Mary-Prey S; Department of Dermatology, Centre Hospitalier Universitaire (CHU) Bordeaux, Bordeaux, France., Beylot-Barry M; Department of Dermatology, Centre Hospitalier Universitaire (CHU) Bordeaux, Bordeaux, France.; BRIC (BoRdeaux Institute of onCology), Institut National de la Santé et de la Recherche Médicale (INSERM), Univ. Bordeaux, Bordeaux, France., Pham-Ledard A; Department of Dermatology, Centre Hospitalier Universitaire (CHU) Bordeaux, Bordeaux, France.; BRIC (BoRdeaux Institute of onCology), Institut National de la Santé et de la Recherche Médicale (INSERM), Univ. Bordeaux, Bordeaux, France., Dutriaux C; Department of Dermatology, Centre Hospitalier Universitaire (CHU) Bordeaux, Bordeaux, France., Sole G; AOC Referral Center for Neuromuscular Diseases, Neurology and Neuromuscular Diseases Department, FILNEMUS, University Hospitals of Bordeaux, Bordeaux, France., Duval F; AOC Referral Center for Neuromuscular Diseases, Neurology and Neuromuscular Diseases Department, FILNEMUS, University Hospitals of Bordeaux, Bordeaux, France., Gerard E; Department of Dermatology, Centre Hospitalier Universitaire (CHU) Bordeaux, Bordeaux, France.

Publikováno v: Frontiers in oncology [Front Oncol] 2024 Jul 08; Vol. 14, pp. 1403658. Date of Electronic Publication: 2024 Jul 08 (Print Publication: 2024).